Human insulin

Por Home, Philip
Publicado em 1986

Safety of very tight blood glucose control in type 2 diabetes

Por Home, Philip
Publicado em 2008

Safety of PPAR Agonists

Por Home, Philip
Publicado em 2011

Insulin Therapy and Cancer

Por Home, Philip
Publicado em 2013

Comment on: Bergenstal et al. A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin–Treated Patients W...

Por Home, Philip D.
Publicado em 2013

Validity of Meta-analysis in Diabetes: We Need to Be Aware of Its Limitations

Por Home, Philip D.
Publicado em 2013

Management of type 2 diabetes: NICE guidelines

Por Sibal, Latika, Home, Philip D
Publicado no Clin Med (Lond) (2009)

Standardisation of glycated haemoglobin: Is a scientific advance, but it could worsen overall blood glucose control

Por Home, Philip, Mbanya, Jean-Claude, Horton, Ed
Publicado em 2004

Should A1C Targets Be Individualized for All People With Diabetes?: Arguments for and against

Por Teoh, Hwee, Home, Philip, Leiter, Lawrence A.
Publicado em 2011

Repeatability of measurements and sources of variability in tests of cardiovascular autonomic function

Por Lawrence, Gillian P, Home, Philip D, Murray, Alan
Publicado em 1992

Management of type 2 diabetes: summary of updated NICE guidance

Por Home, Philip, Mant, Jonathan, Diaz, Jose, Turner, Claire
Publicado em 2008

Carotid intima-media thickness as a surrogate marker of cardiovascular disease in diabetes

Por Sibal, Latika, Agarwal, Sharad C, Home, Philip D
Publicado em 2011

An Overview of Current Regulatory Requirements for Approval of Biosimilar Insulins

Por Heinemann, Lutz, Khatami, Hootan, McKinnon, Ross, Home, Philip
Publicado no Diabetes Technol Ther (2015)

Gestational impaired glucose tolerance does not increase perinatal mortality in a developing country: cohort study

Por Ramtoola, Shenaz, Home, Philip, Damry, Hassen, Husnoo, Anwar, Ah-Kion, Stephen
Publicado em 2001

The Role of Asymmetric Dimethylarginine (ADMA) in Endothelial Dysfunction and Cardiovascular Disease

Por Sibal, Latika, Agarwal, Sharad C, Home, Philip D, Boger, Rainer H
Publicado em 2010

Observational Study of the Association of First Insulin Type in Uncontrolled Type 2 Diabetes with Macrovascular and Microvascular Disease

Por Hall, Gillian C., McMahon, Alex D., Carroll, Dawn, Home, Philip D.
Publicado em 2012

Safety, Tolerability, and Efficacy of Insulin Aspart in People with Type 2 Diabetes, as Biphasic Insulin Aspart or with Basal Insulin: Findings from the Multinational, Non-Interven...

Por Hajjaji, Issam, Shah, Siddharth, Li, Yuxiu, Prusty, Vinay, Benabbas, Youcef, Home, Philip D.
Publicado em 2014

A study of endothelial function and circulating asymmetric dimethylarginine levels in people with Type 1 diabetes without macrovascular disease or microalbuminuria

Por Sibal, Latika, Agarwal, Sharad C, Schwedhelm, Edzard, Lüneburg, Nicole, Böger, Rainer H, Home, Philip D
Publicado em 2009

Impact of Biosimilar Insulins on Clinical Practice: Meeting Report

Por Dolinar, Richard O., Edelman, Steve, Heinemann, Lutz, Home, Philip, Goyal, Shefali, Polonsky, William H., Schellekens, Huub
Publicado no J Diabetes Sci Technol (2014)

Meta-Analysis of Maternal and Neonatal Outcomes Associated with the Use of Insulin Glargine versus NPH Insulin during Pregnancy

Por Lepercq, Jacques, Lin, Jay, Hall, Gillian C., Wang, Edward, Dain, Marie-Paule, Riddle, Matthew C., Home, Philip D.
Publicado em 2012